InvestorNewsBreaks – Clearmind Medicine Inc. (CSE: CMND), The Hebrew University Partner to Focus on Development of Novel Psychedelic Drug
Sep 21, 2021
Clearmind Medicine (CSE: CMND), a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and undertreated health problems, is working with Yissum Research Development Company, the technology transfer company of The Hebrew University of Jerusalem. The two entities are partnering on a research and development project focused on developing novel, innovative, patentable psychedelics as potential drug candidates to expand Clearmind’s IP portfolio.
Yissum has established a global reputation for its ability to discover, analyze and design advanced molecular scaffolds to serve as common platforms for synthesizing various structurally related compounds as potential therapeutic agents and drug candidates. According to the announcement, Clearmind will work with The Hebrew University researchers and professors to analyze and innovate synthetic novel analogs of known psychedelic compounds. In addition, the partnership will involve conducting in silico 3D docking studies and rational design, as well as screening the compounds in an in vitro platform. “This is an important partnership for Clearmind,” said Clearmind CEO Adi Zuloff-Shani, PhD, in the press release. “The academic/technology transfer model is responsible for many medical breakthroughs, and the Hebrew University-Yissum partnership is one of the most prolific in the field. I am certain that our collaboration will yield many potential candidates for further evaluation.”
To view the full press release, visit https://ibn.fm/tdujl
About Clearmind Medicine Inc.
Clearmind is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods or supplements. The company’s intellectual portfolio currently consists of two patent families. The first, Binge Behavior Regulators, has been granted in the United States, Europe, China and India, with pending divisional applications in Europe and the U.S. The second, Alcohol Beverage Substitute, has been approved for a European patent, with pending applications in the U.S., China and India. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio. To learn more about the company, please visit www.ClearmindMedicine.com.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.
More News
After Lockdown, Sea of Protesters Flows Through India’s Capital
The raucous demonstrations by opposition groups on Monday followed days of an effective lockdown and mass detentions of young protesters by security forces.
Europeans Have a Love-Hate Relationship With Chinese Cars
Consumers across the continent increasingly want to buy low-cost Chinese vehicles. Policymakers are seeking to slow them down.
The Taliban Are Using Europe’s Fear of Migrants to Their Advantage
European nations that condemn the Taliban government for its human rights record are seeking its help to deport refugees back to Afghanistan.
What the US and China Should Discuss at APEC
Both sides are feeding an AI investment bubble – and Shenzhen is the place to talk about it.
OpenAI’s GPT-6 may lead to robotics breakthrough as soon as next year: Unitree founder
US start-up OpenAI’s latest advances in artificial intelligence may be a tipping point that leads to a breakthrough for the robotics industry as soon as next year, according to the founder of Chinese giant Unitree Robotics. Wang Xingxing, also the CEO of the Hangzhou-based company, said on Monday that OpenAI’s recently released GPT-6 model prompted expectations that a breakthrough could happen “within one or two years”. “It’s possible that, say, a GPT-7 model released next year could directly...
The Mystery of Kyrgyzstan’s Newly Launched Satellite(s)
At first glance, the story of Kyrgyzstan’s satellite launch seemed like a genuine achievement. Then the story changed.
Australia’s Billionaire Problem and the ‘Corruption of the Democratic Process’
Australia’s incoming political finance laws will cap donations and electioneering spending for the first time, but the limits are generous, the rules complex, and the two-year delay suspiciously convenient for the major parties.
South Korea Recalls Ambassador, Demands Public Apology From Ukraine
A diplomatic rift is growing after a North Korean prisoner transfer that Kyiv revealed against Seoul’s wishes.
India’s opposition marches on Supreme Court as ‘cockroach’ protests gain ground
Indian opposition leaders and student activists marched on the Supreme Court on Monday to demand the resignation of the country’s election chief over alleged voter roll manipulation, as authorities erected heavy barricades and shut six metro stations across New Delhi. The rally went ahead after the Chief Justice of India turned down a meeting request from an opposition delegation, urging them instead to file a formal petition. Mainstream opposition parties have sought to harness a groundswell of...
The China-EU Trade Truce Buys Time
For the EU, the choice is increasingly difficult: secure real concessions from Beijing to address structural trade imbalances or deploy stronger unilateral measures to protect its industrial base.
Southeast Asia Has a Serious Drug Problem
Southeast Asia’s drug labs are pumping out unprecedented amounts of meth and other synthetic drugs.
AI fuelling growth while putting Asia’s young workers at risk, IMF meeting hears
An investment surge into artificial intelligence may be helping prop up a global economy battered by energy supply shocks, but the technology’s potential to cull jobs requires swift mitigation if Asia’s youth are to secure a place in the future workforce, delegates were warned at the IMF–World Bank annual meetings in Bangkok on Monday. Soaring energy prices, persistent inflation and mounting debt framed the opening of the week-long summit, which was last hosted in the Thai capital in...
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.